About 100 reports

  • HER2-POSITIVE BREAST CANCER: KEY METRICS IN THE EIGHT MAJOR PHARMACEUTICAL MARKETS,
  • MM, Diagnosed Incident Cases of HER2+ Invasive Breast Cancer by Site of Metastasis,
  • Cancer
  • Europe
  • Japan
  • Pfizer Inc.
  • Roche Group
  • TREATMENT DURATION IN COLORECTAL CANCER
  • KEY HISTORICAL AND PROJECTED LAUNCH DATES FOR COLORECTAL CANCER
  • Cancer
  • Japan
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • EFFICACY OF AVASTIN IN FIRST LINE METASTATIC BREAST CANCER
  • SAFETY OF AVASTIN IN FIRST-LINE METASTATIC BREAST CANCER
  • Cancer
  • China
  • Japan
  • Novartis AG
  • Pfizer Inc.
  • 6.2.2 Japan - Potential Candidate for Proton Therapy Number and Forecast
  • JAPAN - POTENTIAL CANDIDATE FOR PROTON THERAPY (NUMBER), 2005 - 2015

Anderson Cancer Center Orlando will treat cancers of the brain, spine, lung and prostate as well as pediatric cancers.

  • Cancer
  • Hospital
  • Specialty Hospital
  • Japan
  • World
  • TREATMENT GUIDELINES FOR BLADDER CANCER
  • Opdivo's Development in Bladder Cancer
  • Cancer
  • Europe
  • Japan
  • Merck & Co., Inc.
  • OncoGenex Pharmaceuticals, Inc.
  • RISK FACTORS AND COMORBIDITIES FOR LUNG CANCER
  • MM, SOURCES USED FOR CANCER STAGE AT DIAGNOSIS
  • Cancer
  • Japan
  • Eli Lilly & Co.
  • Novartis AG
  • Pfizer Inc.
  • Herceptin is indicated for the treatment of gastric cancer and breast cancer
  • Gastric cancer drugs market in Japan
  • Cancer
  • Japan
  • World
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • DEVELOPMENT OF ABRAXANE IN GASTRIC CANCER
  • NIMOTUZUMAB'S DEVELOPMENT IN GASTRIC CANCER
  • Cancer
  • Japan
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • MM, Sources Not Used in Epidemiological Analysis of Breast Cancer
  • 2.6.2 Age-Specific Diagnosed Incident Cases of Invasive Breast Cancer
  • Breast Cancer
  • Cancer
  • Pathology
  • Japan
  • Forecast

Key Features of the Report: - Bladder Cancer Patient Flow - Bladder Cancer Prevalence - Bladder Cancer Diagnosed Patients - Bladder Cancer Treated Patients

  • Bladder Cancer
  • Cancer
  • Pathology
  • Europe
  • Japan

Key Features of the Report: - Gastric Cancer Patient Flow - Gastric Cancer Prevalence - Gastric Cancer Diagnosed Patients - Gastric Cancer Treated Patients

  • Cancer
  • Gastric Cancer
  • Pathology
  • Europe
  • Japan

Key Features of the Report: - Small Cell Lung Cancer Patient Flow - Small Cell Lung Cancer Prevalence - Small Cell Lung Cancer Diagnosed Patients - Small Cell Lung Cancer Treated Patients

  • Cancer
  • Pathology
  • Europe
  • Japan
  • World

Key Features of the Report: - Esophageal Cancer Patient Flow - Esophageal Cancer Prevalence - Esophageal Cancer Diagnosed Patients - Esophageal Cancer Treated Patients

  • Cancer
  • Esophageal Cancer
  • Pathology
  • Europe
  • Japan

Key Features of the Report: - Brain Cancer Patient Flow - Brain Cancer Prevalence - Brain Cancer Diagnosed Patients - Brain Cancer Treated Patients

  • Brain Cancer
  • Cancer
  • France
  • Japan
  • Forecast

Key Features of the Report: - Non-Small Cell Lung Cancer Patient Flow - Non-Small Cell Lung Cancer Prevalence - Non-Small Cell Lung Cancer Diagnosed Patients - Non-Small Cell Lung Cancer Treated Patients

  • Cancer
  • Lung Cancer
  • Pathology
  • Europe
  • Japan

Key Features of the Report: - Cervical Cancer Patient Flow - Cervical Cancer Prevalence - Cervical Cancer Diagnosed Patients - Cervical Cancer Treated Patients

  • Cancer
  • Cervical Cancer
  • Pathology
  • Europe
  • Japan

Key Features of the Report: - Colorectal Cancer Patient Flow - Colorectal Cancer Prevalence - Colorectal Cancer Diagnosed Patients - Colorectal Cancer Treated Patients

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Europe
  • Japan

Key Features of the Report: - Cancer Pain Patient Flow - Cancer Pain Prevalence - Cancer Pain Diagnosed Patients - Cancer Pain Treated Patients

  • Cancer
  • Pathology
  • Europe
  • Japan
  • World

Key Features of the Report: - Pancreatic Cancer Patient Flow - Pancreatic Cancer Prevalence - Pancreatic Cancer Diagnosed Patients - Pancreatic Cancer Treated Patients

  • Cancer
  • Pancreatic Cancer
  • Pathology
  • Europe
  • Japan

Key Features of the Report: - Breast Cancer Patient Flow - Breast Cancer Prevalence - Breast Cancer Diagnosed Patients - Breast Cancer Treated Patients

  • Breast Cancer
  • Cancer
  • Pathology
  • Europe
  • Japan

Key Features of the Report: - Prostate Cancer Patient Flow - Prostate Cancer Prevalence - Prostate Cancer Diagnosed Patients - Prostate Cancer Treated Patients

  • Cancer
  • Pathology
  • Prostate Cancer
  • Europe
  • Japan

Key Features of the Report: - Ovarian Cancer Patient Flow - Ovarian Cancer Prevalence - Ovarian Cancer Diagnosed Patients - Ovarian Cancer Treated Patients

  • Cancer
  • Ovarian Cancer
  • Pathology
  • Europe
  • Japan
  • 2.5.3 Age-Standardized Diagnosed Incidence of Ovarian Cancer
  • 2.5 EPIDEMIOLOGICAL FORECAST FOR OVARIAN CANCER (2015-2025)
  • Cancer
  • Epidemiology
  • Ovarian Cancer
  • Japan
  • Forecast

Gastric cancer

4546 5000 3864
  • TREATMENT: GASTRIC CANCER
  • Leading treatments for gastric cancer
  • Cancer
  • Japan
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • 2.5 EPIDEMIOLOGICAL FORECAST FOR BLADDER CANCER (2015-2025)
  • MM, Sources of Bladder Cancer Relative Survival Data
  • Bladder Cancer
  • Cancer
  • Japan
  • United Kingdom
  • Forecast
  • AML CODING SYSTEM BY COUNTRY
  • 5.5.3 DIAGNOSED INCIDENT CASES OF APL
  • Cancer
  • Japan
  • Astellas Pharma Inc.
  • Celgene Corporation
  • Novartis AG
  • and Figure 8 show the age-specific diagnosed incident cases of thyroid cancers in the
  • 3.5 EPIDEMIOLOGICAL FORECAST FOR HNCS AND THYROID CANCER (2014-2024)
  • Cancer
  • Pathology
  • Italy
  • Japan
  • Forecast

Head and neck cancer

4546 5000 3864
  • TNM stage classification
  • List of tables

National Cancer Institute (2016) Head and Neck Cancer.

  • Cancer
  • Ear, Nose, And Throat Medicine
  • Hospital
  • Therapy
  • Japan

Pancreatic cancer

4546 5000 3864
  • LEADING TREATMENTS FOR PANCREATIC CANCER
  • LEADING TREATMENTS FOR PANCREATIC CANCER
  • Cancer
  • Japan
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Taiho Pharmaceutical Co., Ltd.
  • US sales: Increased sales post metastatic gastric cancer approval in 2011
  • OTHER IMPORTANT DETAILS
  • Cancer
  • Japan
  • Biocon Limited
  • Mylan Inc.
  • Roche Group